INS and type 1 diabetes mellitus: During experimental hypoglycaemia, where glucose was reduced in a controlled environment using insulin infusion, hypoglycaemia counterregulation caused a significant increase in circulating adrenaline and noradrenaline concentrations together with a significant decrease in potassium in healthy people [15] and in people with type 2 [15] and type 1 diabetes [14].